BrainSightAI

The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.

Apollo Medical Imaging Technology is a clinically-driven medical imaging software company specializing in the creation of advanced image processing software for clinical and research applications. Their flagship product, MIStar, is a fast, economical, and easy-to-use software package that provides a broad spectrum of advanced functions and cost-effective cross-modality solutions for clinicians and the OEMs that serve them. MIStar supports various imaging modalities, including CT, MR, NM, and PET, and offers advanced modules such as CT Perfusion for stroke, brain tumor, body tumor, liver, kidney, and prostate; DSC-MRI for stroke; DCE-MRI for brain tumor, breast, body tumor, liver, kidney, and prostate; DWI & ADC; DTI Fiber Tractography; NM Renogram Analysis; and Image Fusion. The software features data access and image input through DICOM networking functions, an intuitive clinical database, and easy anonymization and archiving.